krabeva bevacizumab (r-dna origin) concentrate for solution for intravenous infusion 25mgml
biocon sdn bhd - bevacizumab -
insugen-r (regular) insulin injection soluble 100iuml
biocon sdn bhd - insulin human -
insugen-n (nph) insulin injection isophane 100iuml
biocon sdn bhd - insulin human -
insugen-r (regular) insulin injection soluble 100iuml
biocon sdn bhd - insulin human -
insugen-3070 (biphasic) insulin injection biphasic isophane 100iuml
biocon sdn bhd - insulin human -
pegil
unipharm trading ltd, israel - pegfilgrastim - solution for injection - pegfilgrastim 10 mg/ml - pegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy, given at intervals of 14 days or more, for malignancy. (with the exception of chronic myeloid leukemia and myelodysplastic syndromes).
fulphila 6 mg 0.6 ml solution for injection
biocon sdn bhd - pegfilgrastim -
kirsty insulin aspart injection (rdna origin) 100 uml
biocon sdn bhd - insulin aspart -
optimol biological insecticide optimiser
agbitech pty ltd - sugars; petroleum oil - emulsion - oil in water - sugars food active 600.0 g/l; petroleum oil petroleum derivative-oil active 175.0 g/l - insecticide - insecticide additive | additive - improve performance | under adverse environmental co
exudate-absorbent dressing, hydrophilic-gel
bioconnexus australia pty ltd - 43186 - exudate-absorbent dressing, hydrophilic-gel - assists in wound healing by absorbing exudate in wounds (e.g., ulcers, burns, surgical wounds, lacerations, abrasions) for minimal wound maceration, allowing wound debridement, and creating a moist wound-healing environment.